loratadine has been researched along with thiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazís, P; de Mora, F; Merlos, M; Puigdemont, A; Queralt, M | 1 |
| Gleixner, KV; Hadzijusufovic, E; Mirkina, I; Peter, B; Pickl, WF; Schuch, K; Thaiwong, T; Valent, P; Willmann, M; Yuzbasiyan-Gurkan, V | 1 |
| Jójártné, LO; Mártha, C; Szabóné, RP | 1 |
3 other study(ies) available for loratadine and thiazoles
| Article | Year |
|---|---|
In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1.
Topics: Animals; Antibodies; Calcimycin; Cell Line; Concanavalin A; Cyproheptadine; Dogs; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Loratadine; Mast Cells; Skin; Thiazoles; Tumor Necrosis Factor-alpha | 2000 |
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cats; Cell Line, Tumor; Cell Proliferation; Dasatinib; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Histamine H1 Antagonists, Non-Sedating; Humans; Inhibitory Concentration 50; Loratadine; Mastocytoma; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Pyrimidines; Staurosporine; Terfenadine; Thiazoles; Tumor Cells, Cultured | 2010 |
[Amorphous form in pharmaceutical technological research].
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chlorhexidine; Clopidogrel; Dihydropyridines; Gemfibrozil; Glass; Ibuprofen; Loratadine; Meloxicam; Pharmaceutical Preparations; Piroxicam; Sorbitol; Technology, Pharmaceutical; Thiazines; Thiazoles; Ticlopidine | 2011 |